Who we are
SANIFIT is a biotechnology company focused on treatments for calcification disorders.
SANIFIT started activities in 2007 and has now operations in Spain and Switzerland.
read moreLeading drug candidate
SNF 472: For ESRD, hemodialysis patients
Patients with chronic kidney disease (CKD) suffer from accelerated calcification and increase rate of CV events. End stage renal disease (ESRD) patients require on dialysis and calcification is further accelerated, with an average life-expectancy of 5-6 years.
read more- NEWS 02/03/2011 Sanifit setting up an International Scientific Advisory Committee with incorporation of Dr Rainer Henning
- NEWS 05/04/2011 Prof. David Goldfarb, (Head of Nephrology, New York University/ VA Medical Center) joins Sanifit’s Scientific Advisory Committee
- NEWS 15/06/2011 Dariusch Mani, Ph.D. joins Sanifit’s management team as Chief Executive Officer
- NEWS 30/06/2011 Pieter Joubert, M.D. former Global Head of Clinical Pharmacology, Roche (Switzerland) joins Sanifit’s management team as Chief Medical Officer
